Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma - Agache, I; Rocha, C; Beltran, J; Song, Y; Posso, M; Sola, I; Alonso-Coello, P; Akdis, C; Akdis, M; Canonica, GW; Casale, T; Chivato, T; et al. (ALLERGY, 2020)